Contracting for Anthrax Vaccine.
Abstract
This audit was requested by Congressman Walter B. Jones to review the financial and contractual relationship between the DoD and BioPort Corporation, the sole U.S. manufacturer of the anthrax vaccine. Specifically, Congressman Jones requested we review the renegotiation of the sole source Anthrax Vaccine Adsorbed contract that increased financial assistance to BioPort Corporation. In 1970, the Food and Drug Administration granted the only Anthrax Vaccine Adsorbed license in the United States to the State of Michigan. Prior to September 1998, Michigan Biologic Products Institute, a facility in Lansing, Michigan, owned by the State of Michigan, manufactured the Anthrax Vaccine Adsorbed. In December 1995, the State of Michigan decided to initiate a privatization of Michigan Biologic Products Institute. In November 1996, the Food and Drug Administration inspected the Michigan Biologic Products Institute and in March 1997 issued a notice of intent to revoke their license. On September 4, 1998, BioPort Corporation acquired the Michigan Biologic Products Institute from the State of Michigan for about $24.75 million in a combination of cash, loans, products, and royalties. As part of the sale, Michigan Biologic Products Institute agreed to enter into a novation agreement that transferred three DoD contracts to BioPort Corporation.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 22, 2000
- Accession Number
- ADA378857
Entities
Organizations
- Office of the Inspector General, U.S. Department of Defense